Today's Low
₹ 21.85
Today's High
₹ 22.05
52 Weeks Low
₹ 17.15
52 Weeks High
₹ 32.45
Lower
₹ 22.00
Upper
₹ 22.85
Sanginita Chemicals Limited manufactures and exports cuprous chloride, cupric chloride, and copper sulphate in India. The company also offers copper phthalocyanine blue crude. Its products are used in dyes and pigment industries, paint industries, pharmaceuticals industries, electroplating industries, metal extraction industries and ink, carbon paper, PVC pipe coating industries, etc. Sanginita Chemicals Limited was incorporated in 2005 and is headquartered in Gandhinagar, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 70.3 | 74.9 | 65.8 | 73.7 | 67.0 | 56.9 | 56.5 | 40.2 | 46.1 | 39.5 | 35.8 | 34.8 |
Total Non-Current Assets | 9.2 | 4.3 | 4.3 | 4.7 | 4.6 | 4.1 | 3.6 | 3.8 | 4.1 | 4.6 | 5.1 | 5.1 |
Total Assets | 79.5 | 79.2 | 70.1 | 78.4 | 71.6 | 61.0 | 60.1 | 43.9 | 50.2 | 44.1 | 41.0 | 39.9 |
Total Current Liabilities | 37.3 | 35.9 | 30.5 | 39.5 | 35.9 | 28.9 | 31.5 | 26.3 | 33.9 | 28.6 | 26.6 | 26.1 |
Total Non-Current Liabilities | 2.1 | 3.6 | 0.2 | 0.3 | 0.4 | 0.7 | 0.7 | 0.9 | 1.0 | 1.2 | 0.9 | 0.8 |
Shareholder's Funds | 40.1 | 39.7 | 39.4 | 38.6 | 35.2 | 31.3 | 27.9 | 16.7 | 15.3 | 14.3 | 13.5 | 12.9 |
Total Liabilities | 79.5 | 79.2 | 70.1 | 78.4 | 71.6 | 61.0 | 60.1 | 43.9 | 50.2 | 44.1 | 41.0 | 39.9 |
The Industry Quick Ratio stands at 1.42, vs the Quick Ratio of 1.16, which results in a Negative aspect.
The Industry Current Ratio stands at 2.17, vs the Current Ratio of 1.89, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.37, vs the Debt to Equity Ratio of 0.71, which results in a Negative aspect.
The Industry Price to BV stands at 10.49, vs the Price to BV of 0.91, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Income | 148.6 | 198.1 | 164.7 | 159.8 | 187.6 | 194.6 | 154.7 | 151.5 | 128.7 | 119.0 | 96.5 | 107.0 |
Total Expenditure | 145.5 | 195.3 | 160.8 | 151.5 | 178.5 | 186.6 | 149.8 | 146.9 | 124.3 | 117.0 | 91.7 | 100.7 |
Operating Profit(Excl OI) | 3.6 | 3.1 | 4.2 | 8.5 | 9.3 | 8.1 | 5.1 | 4.8 | 4.6 | 2.1 | 4.7 | 6.3 |
Add: Other Income | 0.6 | 0.4 | 0.4 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.3 | 0.0 | 0.0 | 0.0 |
Operating Profit | 3.6 | 3.1 | 4.2 | 8.5 | 9.3 | 8.1 | 5.1 | 4.8 | 4.6 | 2.1 | 4.7 | 6.3 |
Less: Interest | 2.5 | 2.1 | 2.6 | 3.3 | 3.2 | 2.4 | 2.9 | 2.7 | 2.6 | 0.0 | 3.9 | 3.9 |
PBDT | 1.1 | 1.0 | 1.6 | 5.2 | 6.1 | 5.7 | 2.2 | 2.1 | 2.0 | 2.1 | 0.8 | 2.4 |
Less: Depreciation Amortization | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | 0.5 | 0.5 | 0.5 | 0.6 | 0.6 | 0.0 | 0.0 |
PBT & Exceptional Items | 0.6 | 0.5 | 1.0 | 4.5 | 5.5 | 5.2 | 1.7 | 1.6 | 1.5 | 1.4 | 0.8 | 2.4 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 0.6 | 0.5 | 1.0 | 4.5 | 5.5 | 5.2 | 1.7 | 1.6 | 1.5 | 1.4 | 0.8 | 2.4 |
Less: Taxation | 0.1 | 0.1 | 0.3 | 1.1 | 1.5 | 1.7 | 0.6 | 0.5 | 0.5 | 0.6 | 0.2 | 0.8 |
Profit After Tax | 0.4 | 0.4 | 0.8 | 3.4 | 3.9 | 3.5 | 1.1 | 1.1 | 1.0 | 0.8 | 0.6 | 1.5 |
Earnings Per Share | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
The Industry PAT Growth stands at 32.62, vs the PAT Growth of 19.57, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.42, vs the Dividend Yield of 0.00, which results in a Negative aspect.
The Industry PAT Margin stands at 13.19, vs the PAT Margin of 0.28, which results in a Negative aspect.
The Industry PE Ratio stands at 58.81, vs the PE Ratio of 30.11, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Profit Before Tax | 0.6 | 0.5 | 1.0 | 4.5 | 5.5 | 5.2 | 1.7 | 1.6 | 1.5 | 1.4 | 0.8 | 2.4 |
Tax Paid | -0.1 | -0.3 | -1.1 | -1.5 | -1.7 | -1.7 | -0.6 | -0.5 | -0.5 | -0.5 | -0.3 | -0.8 |
Adjustment | 2.9 | 2.5 | 3.1 | 3.9 | 3.8 | 2.9 | 3.3 | 3.2 | 3.0 | 3.6 | 3.9 | 3.9 |
Changes In Working Capital | 0.6 | 0.5 | 1.0 | 4.5 | 5.5 | 5.2 | 1.7 | 1.6 | 1.5 | 1.4 | 0.8 | 2.4 |
Cash Flow after changes in Working Capital | 13.8 | -2.7 | 9.7 | -0.1 | 2.3 | 4.5 | -6.8 | 0.7 | 2.7 | 5.9 | 4.2 | -4.0 |
Cash Flow from Operating Activities | 13.7 | -3.0 | 8.5 | -1.6 | 0.6 | 2.8 | -7.4 | 0.2 | 2.3 | 5.4 | 3.9 | -4.7 |
Cash Flow from Investing Activities | -0.7 | -0.5 | -0.1 | -0.7 | -0.8 | -1.1 | -0.1 | -0.1 | 0.0 | -0.1 | -1.0 | -0.3 |
Cash Flow from Financing Activities | -13.0 | 3.5 | -8.4 | 2.3 | 0.2 | -1.9 | 7.7 | -0.1 | -2.3 | -5.3 | -2.9 | 5.0 |
Net Cash Inflow / Outflow | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Opening Cash & Cash Equivalents | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Closing Cash & Cash Equivalent | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
The Industry PCF RATIO stands at 1.34, vs the PCF RATIO of 2.39, which results in a Positive aspect.
The Industry PFCF Ratio stands at -109.98, vs the PFCF Ratio of 3.13, which results in a Positive aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 291.6 | 334.1 | 359.0 | 338.2 | 335.1 | 301.4 | 510.9 | 387.5 | 519.9 | 499.5 | 573.8 | 533.2 | 369.0 | 476.7 | 267.7 | 372.6 |
Total Income | 294.1 | 334.9 | 359.7 | 339.3 | 335.5 | 304.0 | 512.5 | 388.3 | 520.8 | 500.0 | 575.3 | 534.3 | 370.7 | 477.2 | 268.1 | 373.3 |
Total Expenditure | 279.4 | 319.8 | 346.8 | 332.4 | 323.9 | 295.8 | 503.2 | 388.2 | 523.2 | 483.5 | 558.4 | 528.8 | 364.7 | 452.8 | 261.4 | 367.9 |
PBIDT (Excl OI) | 12.2 | 14.3 | 12.1 | 5.9 | 11.1 | 5.7 | 7.8 | -0.6 | -3.3 | 16.0 | 15.3 | 4.4 | 4.4 | 23.8 | 6.3 | 4.7 |
Other Income | 2.5 | 0.8 | 0.7 | 1.1 | 0.5 | 2.5 | 1.6 | 0.8 | 0.9 | 0.4 | 1.6 | 1.1 | 1.6 | 0.5 | 0.4 | 0.7 |
Operating Profit | 14.7 | 15.1 | 12.8 | 7.0 | 11.6 | 8.2 | 9.3 | 0.2 | -2.4 | 16.5 | 16.9 | 5.5 | 6.0 | 24.3 | 6.7 | 5.4 |
Interest | 6.6 | 6.2 | 6.6 | 6.8 | 6.3 | 6.0 | 5.9 | 5.1 | 5.1 | 5.7 | 4.9 | 5.3 | 7.0 | 6.5 | 6.9 | 8.5 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 8.1 | 8.9 | 6.2 | 0.1 | 5.3 | 2.2 | 3.5 | -4.9 | -7.5 | 10.8 | 12.1 | 0.1 | -1.0 | 17.9 | -0.2 | -3.2 |
Depreciation | 2.0 | 1.6 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.5 | 1.4 | 1.3 | 1.7 | 1.7 | 1.8 | 1.5 | 2.3 |
Profit Before Tax | 6.2 | 7.4 | 4.7 | -1.3 | 3.9 | 0.9 | 2.1 | -6.4 | -9.0 | 9.4 | 10.7 | -1.5 | -2.7 | 16.1 | -1.7 | -5.4 |
Tax | 1.6 | 1.9 | 1.2 | -0.3 | 1.0 | 0.2 | 0.5 | -1.6 | 0.0 | 2.4 | 2.7 | -0.4 | 0.0 | 3.6 | 0.0 | -2.7 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 4.6 | 5.5 | 3.5 | -1.0 | 2.9 | 0.7 | 1.6 | -4.8 | -9.0 | 7.0 | 8.0 | -1.2 | -2.7 | 12.5 | -1.7 | -2.7 |
Net Profit | 4.6 | 5.5 | 3.5 | -1.0 | 2.9 | 0.7 | 1.6 | -4.8 | -9.0 | 7.0 | 8.0 | -1.2 | -2.7 | 12.5 | -1.7 | -2.7 |
ADDITIONAL INFOS: | ||||||||||||||||
Equity Capital | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 | 172.7 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 0.3 | 0.3 | 0.2 | -0.1 | 0.2 | 0.0 | 0.1 | -0.3 | -0.5 | 0.4 | 0.5 | -0.1 | -0.2 | 0.7 | -0.1 | -0.2 |
Operating Profit Margin | 5.1 | 4.5 | 3.6 | 2.1 | 3.5 | 2.7 | 1.8 | 0.0 | -0.5 | 3.3 | 2.9 | 1.0 | 1.6 | 5.1 | 2.5 | 1.4 |
Net Profit Margin | 1.6 | 1.6 | 1.0 | -0.3 | 0.9 | 0.2 | 0.3 | -1.2 | -1.7 | 1.4 | 1.4 | -0.2 | -0.7 | 2.6 | -0.6 | -0.7 |
The Industry Net Sales Growth stands at 28.30, vs the Net Sales Growth of -24.99, which results in a Negative aspect.
The Industry Mcap Growth stands at -5.06, vs the Mcap Growth of -9.33, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 22.55 | 22.93 | 22.12 |
R3 | 22.45 | 22.40 | 22.03 |
R2 | 22.35 | 22.33 | 22.01 |
R1 | 22.15 | 22.10 | 21.98 |
Pivot | 22.05 | 22.03 | 22.05 |
S1 | 21.85 | 21.80 | 21.92 |
S2 | 21.75 | 21.73 | 21.90 |
S3 | 21.55 | 21.50 | 21.87 |
S4 | 21.35 | 21.13 | 21.79 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
67.67
Neutral
RSI
39.89
Neutral
ROC
2.80
Bullish
UltimateOscillator
34.16
Neutral
Williams Indicator
-47.79
Neutral
CCI Indicator
-12.01
Neutral
MACD
-2,908.33
Bearish
Stochastic Indicator
53.69
Neutral
ATR
0.88
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
11-01-2024 | Financial Results |
13-10-2023 | SANGINITA CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 13-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2023 . |
16-08-2023 | SANGINITA CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 16-Aug-2023 to consider Other business. |
14-07-2023 | Financial Results/Fund Raising |
18-04-2023 | Financial Results |
11-01-2023 | Financial Results |
13-10-2022 | Financial results |
19-07-2022 | Financial results |
27-04-2022 | Financial results |
11-01-2022 | Financial Results |
13-10-2021 | Financial Results |
16-07-2021 | Financial Results |
13-05-2021 | Financial Results |